kalshi
Science and Technology
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?
before September
26%
implied YES probability
-17.0pp 24h
Price history
Last 9 days ·
High 46% ·
Low 31%
· 7d -11.4pp
Other outcomes in this event
Related stocks
Trade on Kalshi
Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate
public order-book and trading data for analysis.
Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.